BELLEDERM SKINCARE, LLC – Trademark Portfolio
Entity Type: 16
BELLEDERM SKINCARE, LLC holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include BELLEDERM. The owner is based in CARROLLTON, TX.
2225 EAST BELTLINE ROAD, SUITE 106
CARROLLTON, TX 75007
Showing of trademarks Trademarks
Trademark Classifications
BELLEDERM SKINCARE, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does BELLEDERM SKINCARE, LLC have?
BELLEDERM SKINCARE, LLC has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 abandoned, 1 cancelled.
What trademark classes does BELLEDERM SKINCARE, LLC file in?
BELLEDERM SKINCARE, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are BELLEDERM SKINCARE, LLC's most well-known trademarks?
BELLEDERM SKINCARE, LLC's registered trademark portfolio includes well-known marks such as BELLEDERM. These are among 1 currently registered trademark in the portfolio.
What is BELLEDERM SKINCARE, LLC's trademark registration success rate?
BELLEDERM SKINCARE, LLC has a 25% trademark registration rate, with 1 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.